In vitro expanded NK cells combined with rituximab can efficiently lyse autologous B-CLL cells and overcome the natural resistance to NK cell mediated killing.

被引：0
|
作者：
Broady, R
Golay, J
Gramigna, R
Facchinetti, V
Borleri, G
Salvi, A
Barbui, T
Introna, M
Rambaldi, A
机构：
[1] Osped Riuniti Bergamo, Div Hematol, I-24100 Bergamo, Italy
[2] Ist Ric Farmacol Mario Negri, Lab Mol Immunohematol, Milan, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3172
引用
收藏
页码：803A / 803A
页数：1
相关论文
共 50 条
  • [41] Natural killer (NK) cell-mediated cytolysis of Plasmodium falciparum-infected human red blood cells in vitro
    Mavoungou, E
    Luty, AJF
    Kremsner, PG
    EUROPEAN CYTOKINE NETWORK, 2003, 14 (03) : 134 - 142
  • [42] EFFECT OF MG4101, RANDOM DONOR DERIVED, EX VIVO-EXPANDED NK CELLS, IN COMBINATION WITH RITUXIMAB IN B CELL LYMPHOMA MODEL
    Her, J.
    Lee, E.
    Gwon, S.
    Cho, S.
    Hwang, Y.
    CYTOTHERAPY, 2017, 19 (05) : S37 - S37
  • [43] Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
    Spaggiari, GM
    Capobianco, A
    Becchetti, S
    Mingari, MC
    Moretta, L
    BLOOD, 2006, 107 (04) : 1484 - 1490
  • [44] Dietary products induce apoptosis in CLL B cells and reveal potential as a therapeutic combination that can overcome stromal cell mediated protection
    Ghosh, Asish K.
    Shanafelt, Tait D.
    Secreto, Charla
    Kay, Neil E.
    BLOOD, 2007, 110 (11) : 921A - 921A
  • [45] CLINICAL STUDY OF AUTOLOGOUS NATURAL KILLER CELLS COMBINED WITH RITUXIMAB FOR THE TREATMENT OF ELDERLY PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
    Cui, J. W.
    Li, W.
    Bai, O.
    Liu, C. S.
    Li, D.
    Jin, H. F.
    HAEMATOLOGICA, 2012, 97 : 319 - 320
  • [46] Rituximab causes a polarization of B cells that augments its therapeutic function in NK-cell-mediated antibody-dependent cellular cytotoxicity
    Rudnicka, Dominika
    Oszmiana, Anna
    Finch, Donna K.
    Strickland, Ian
    Schofield, Darren J.
    Lowe, David C.
    Sleeman, Matthew A.
    Davis, Daniel M.
    BLOOD, 2013, 121 (23) : 4694 - 4702
  • [47] NK cell-mediated lysis is essential to kill Epstein-Barr virus transformed lymphoblastoid B cells when using rituximab
    Markasz, Laszlo
    Vanherberghen, Bruno
    Flaberg, Emilie
    Otvos, Rita
    Stuber, Gyorgy
    Jernberg, Asa Gustafsson
    Olah, Eva
    Skribek, Henriette
    Szekely, Laszlo
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (06) : 413 - 420
  • [48] Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle
    Williams, Luke R.
    Quinn, Laura L.
    Rowe, Martin
    Zuo, Jianmin
    JOURNAL OF VIROLOGY, 2016, 90 (02) : 947 - 958
  • [49] Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting (vol 9, e001334, 2021)
    Eitler, J.
    Wotschel, N.
    Miller, N.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [50] Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant
    Holthof, Lisa C.
    Stikvoort, Arwen
    van der Horst, Hilma J.
    Gelderloos, Anne T.
    Poels, Renee
    Li, Fengzhi
    Groen, Richard W. J.
    Zweegman, Sonja
    van de Donk, Niels W. C. J.
    O'Dwyer, Michael
    Mutis, Tuna
    HEMASPHERE, 2021, 5 (05):
12345